Flagship Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,113
Closed -$43.8K 228
2021
Q2
$43.8K Hold
1,113
0.03% 139
2021
Q1
$40.4K Sell
1,113
-27
-2% -$959 0.03% 125
2020
Q4
$41.3K Buy
+1,140
New +$41.8K 0.04% 125

Other funds holding PFE

Flagship Private Wealth's PFE Position: Q3 2021 in Review

Flagship Private Wealth sold out of Pfizer (PFE) in Q3 2021, closing a stake of 1,113 shares — an estimated $43.8K sold.

Flagship Private Wealth first reported a position in PFE in Q4 2020 and held it in 3 quarters. The position peaked at $43.8K in Q2 2021. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Flagship Private Wealth reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
  • Flagship Private Wealth sold 1,113 Pfizer shares in Q3 2021, an estimated $43.8K.
  • Flagship Private Wealth first reported a position in Pfizer in Q4 2020 and held it in 3 quarters.
  • Flagship Private Wealth's Pfizer position peaked at $43.8K in Q2 2021.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Flagship Private Wealth's 13F filing for Q3 2021, filed 20 Oct 2021.